Phase 2 Efficacy Trial of Z160 in Lumbosacral Radiculopathy
NCT01655849
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
141
Enrollment
INDUSTRY
Sponsor class
Conditions
Lumbosacral Radiculopathy
Interventions
DRUG:
z160
DRUG:
Placebo
Sponsor
Zalicus